US 7,250,419 · Application 11/230,493
US Patent 7,250,419 — assignment history and current owner
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
Who owns US Patent 7,250,419?
US7250419 ("Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition") — current assignee: ASTRAZENECA UK LIMITED. Status: Expired. 1 recorded USPTO assignment.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 7,250,419 is ASTRAZENECA UK LIMITED. Based on the most recent ownership transfer record (recorded 2015-03-13).
- Patent title
- Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
- Application number
- 11/230,493
- Apparent operating assignee
- ASTRAZENECA UK LIMITED
- Patent status
- Expired
- Recorded assignments
- 1
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Feb 28, 2000 | Mar 13, 2015 | Ownership Transfer | GUILE, SIMON; HARDERN, DAVID; INGALL, ANTHONY; SPRINGTHORPE, BRIAN; WILLIS, PAUL | ASTRAZENECA UK LIMITED | 35165/112 |
Scrolls sideways on narrow screens
Chain of title
In 2015, GUILE, SIMON; HARDERN, DAVID (+3 more) assigned the patent to ASTRAZENECA UK LIMITED.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
The prosecution record for your AI
Application 11/230,493 · US 7,250,419
Ownership settled? Give your AI the file.
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 7,250,419, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.